Global Botulinum Toxin Market 2017-2021


◆タイトル:Global Botulinum Toxin Market 2017-2021
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆資料形式:PDF / 英語
Single User(1名利用)USD3,500 ⇒換算¥385,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,500 ⇒換算¥495,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。



ABSTRACTAbout Botulinum Toxin

Botulinum toxin is a chemical substance, which is used as a drug to regulate the release of acetylcholine, the chemical that regulates the neuron flow in the nervous system to activate the muscles. To be used as a drug, botulinum toxin must be isolated, purified, and stabilized. This substance finds its place largely as one of the most sought-after muscle relaxants in the modern pharma industry for multiple indications such as cosmetic surgery, skeletal muscle relaxants, and neuromuscular relaxants to name a few.

Technavio’s analysts forecast the global botulinum toxin market to grow at a CAGR of 8.16% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global botulinum toxin market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas

Technavio’s report, Global Botulinum Toxin Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Galderma
• Ipsen
• Merz Pharma
• Pfizer

[Other prominent vendors]
• Acorda Therapeutics
• Aldeyra Therapeutics
• Azidus Brasil
• Biolab Sanus Farmaceutica
• Canbex Therapeutics
• Emcure Pharmaceuticals
• Endo Pharmaceuticals International
• Evolus
• Fresenius Kabi
• GlaxoSmithKline
• Johnson & Johnson
• Lannett
• Lanzhou Institute of Biological Products
• LEO Pharma
• Mylan
• Par Pharmaceuticals
• PhytoTech Therapeutics
• Revance Therapeutics
• Sun Pharmaceuticals
• Takeda Pharmaceutical
• UroGen Pharma

[Market driver]
• Rising demand for non-invasive solutions in cosmetology.
• For a full, detailed list, view our report

[Market challenge]
• Side effects associated with the use of facial aesthetic products.
• For a full, detailed list, view our report

[Market trend]
• Growing demand for anti-aging treatment.
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Key market highlights

PART 05: Botulinum toxin: An overview

PART 06: Pipeline landscape

PART 07: Market landscape
• Five forces analysis

PART 08: Market segmentation by drug categories
• Aesthetic drugs market
• Therapeutic drugs market

PART 09: Geographical segmentation
• Botulinum toxin market in Americas
• Botulinum toxin market in EMEA
• Botulinum toxin market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges
• Market drivers
• Impact of drivers on key customer segments
• Market challenges
• Impact of challenges on key customer segments

PART 12: Market trends
• Growing importance of medical aesthetics
• Technological advancement
• Growing demand for anti-aging treatment

PART 13: Vendor landscape
• Competitive landscape
• Key news

PART 14: Key vendor analysis
• Galderma
• Ipsen
• Merz Pharma
• Pfizer
• Other prominent vendors

PART 15: Appendix
• List of abbreviations

[List of Exhibits]

Exhibit 01: Pipeline landscape
Exhibit 02: Global botulinum toxin market: Snapshot
Exhibit 03: Global botulinum toxin market 2016-2021 ($ millions)
Exhibit 04: Global botulinum toxin market: Opportunity analysis
Exhibit 05: Five forces analysis
Exhibit 06: Market segmentation by drug category 2016
Exhibit 07: Global aesthetic drugs market 2016-2021 ($ millions)
Exhibit 08: Global therapeutic drugs market 2016-2021 ($ millions)
Exhibit 09: Segmentation of global botulinum toxin market based on geography 2016 and 2021
Exhibit 10: Global botulinum toxin market revenue by geography 2016-2021 ($ millions)
Exhibit 11: Market scenario in Americas
Exhibit 12: Botulinum toxin market in Americas 2016-2021 ($ millions)
Exhibit 13: Market scenario in EMEA
Exhibit 14: Botulinum toxin market in EMEA 2016-2021 ($ millions)
Exhibit 15: Market scenario in APAC
Exhibit 16: Botulinum toxin market in APAC 2016-2021 ($ millions)
Exhibit 17: Key R&D-based growth drivers
Exhibit 18: Impact of drivers
Exhibit 19: Impact of challenges
Exhibit 20: Top five non-surgical procedures (injectable) of 2015
Exhibit 21: Competitive structure analysis of global botulinum toxin market 2016
Exhibit 22: Competitive analysis of global botulinum toxin market 2016
Exhibit 23: Global market penetration of players in botulinum toxin market 2016
Exhibit 24: ALLERGAN: Key highlights
Exhibit 25: ALLERGAN: Strength assessment
Exhibit 26: ALLERGAN: Strategy assessment
Exhibit 27: ALLERGAN: Opportunity assessment
Exhibit 28: Galderma: Key highlights
Exhibit 29: Galderma: Strength assessment
Exhibit 30: Galderma: Strategy assessment
Exhibit 31: Galderma: Opportunity assessment
Exhibit 32: Ipsen: Key highlights
Exhibit 33: Ipsen: Strength assessment
Exhibit 34: Ipsen: Strategy assessment
Exhibit 35: Ipsen: Opportunity assessment
Exhibit 36: Merz Pharma: Key highlights
Exhibit 37: Merz Pharma: Strength assessment
Exhibit 38: Merz Pharma: Strategy assessment
Exhibit 39: Merz Pharma: Opportunity assessment
Exhibit 40: Pfizer: Strength assessment
Exhibit 41: Pfizer: Strategy assessment
Exhibit 42: Pfizer: Opportunity assessment





★調査レポート[ボツリヌス毒素の世界市場2017-2021] (Global Botulinum Toxin Market 2017-2021 / IRTNTR11691)販売に関する免責事項
[ボツリヌス毒素の世界市場2017-2021] (Global Botulinum Toxin Market 2017-2021 / IRTNTR11691)についてEメールでお問い合わせ